Quick10K

⚲

Accelerate Diagnostics

Filings

10-K	2020-12-31	Filed 2021-03-02
10-Q	2020-09-30	Filed 2020-11-06
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-08
10-K	2019-12-31	Filed 2020-02-28
10-Q	2019-09-30	Filed 2019-11-08
10-Q	2019-06-30	Filed 2019-08-08
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-01
10-Q	2018-09-30	Filed 2018-11-06
10-Q	2018-06-30	Filed 2018-08-07
10-Q	2018-03-31	Filed 2018-05-10
10-K	2017-12-31	Filed 2018-03-01
10-Q	2017-09-30	Filed 2017-11-07
10-Q	2017-06-30	Filed 2017-08-07
10-Q	2017-03-31	Filed 2017-05-05
10-K	2016-12-31	Filed 2017-02-28
10-Q	2016-09-30	Filed 2016-11-09
10-Q	2016-06-30	Filed 2016-08-08
10-Q	2016-03-31	Filed 2016-05-10
10-K	2015-12-31	Filed 2016-03-09
10-Q	2015-09-30	Filed 2015-11-02
10-Q	2015-06-30	Filed 2015-07-31
10-Q	2015-03-31	Filed 2015-05-07
10-K	2014-12-31	Filed 2015-02-26
10-Q	2014-09-30	Filed 2014-11-04
10-Q	2014-06-30	Filed 2014-08-01
10-Q	2014-03-31	Filed 2014-05-02
10-K	2013-12-31	Filed 2014-03-07
10-Q	2013-09-30	Filed 2013-11-08
10-Q	2013-06-20	Filed 2013-08-09
10-Q	2013-03-31	Filed 2013-05-10
10-Q	2012-10-31	Filed 2012-12-14
10-K	2012-07-31	Filed 2012-10-26
10-Q	2012-04-30	Filed 2012-06-13
10-Q	2012-01-31	Filed 2012-03-15
10-Q	2011-10-31	Filed 2011-12-14
10-K	2011-07-31	Filed 2011-10-27
10-Q	2011-04-30	Filed 2011-06-14
10-Q	2011-01-31	Filed 2011-03-16
10-Q	2010-10-31	Filed 2010-12-14
10-K	2010-07-31	Filed 2010-09-16
10-Q	2010-04-30	Filed 2010-06-14
10-Q	2010-01-31	Filed 2010-03-17

Reports

8-K	2021-02-19	Earnings, Other Events, Exhibits
8-K	2021-01-12	Earnings, Regulation FD, Exhibits
8-K	2020-12-24	Enter Agreement, Sale of Shares, Regulation FD, Exhibits
8-K	2020-11-05
8-K	2020-09-17
8-K	2020-08-18
8-K	2020-08-06
8-K	2020-06-29
8-K	2020-06-22
8-K	2020-05-08
8-K	2020-05-04
8-K	2020-04-15
8-K	2020-04-14
8-K	2020-03-24
8-K	2020-02-27
8-K	2020-01-31
8-K	2020-01-13
8-K	2019-12-20
8-K	2019-12-01
8-K	2019-11-07
8-K	2019-10-31
8-K	2019-08-20
8-K	2019-08-02
8-K	2019-05-10
8-K	2019-05-09
8-K	2019-02-19
8-K	2019-01-06
8-K	2018-12-21
8-K	2018-12-04
8-K	2018-11-06
8-K	2018-09-25
8-K	2018-08-06
8-K	2018-05-09
8-K	2018-05-03
8-K	2018-03-22
8-K	2018-02-15
8-K	2018-01-10

Accelerate Diagnostics Financials

AXDX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
Banner Energy Services Corp. (BANM)
AVIENT CORP (AVNT)
11 Good Energy (ELVN)
COWEN INC. (COWNL)
1347 Capital Corp (TFSC)
CAI International, Inc. (CAI-PA)
Avianca Holdings S.A. (AVHOQ)
Gamco Investors (GBL)	506	0%	4.3	45%	179	147	307	0	81	103	444
BANK BRADESCO (BBDO)
BIO-RAD LABORATORIES, INC. (BIO-B)
Fortress Transportation & Infrastructure Investors LLC (FTAI-PC)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Intevac (IVAC)	107	33%	-678.8	-3%	124	35	73	24	-4	-0	90
1st United Bancorp (FUBC)
CIT GROUP INC (CIT-PB)
2-Track Global (TTG)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-10-31	2012-01-31	2012-04-30	2012-07-31	2012-10-31	2013-03-31	2013-06-20	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	1	1	0	14	13	29	27	33	30	26	65	58	54	47	35	25	121	72	38	29	19	10	63	34	29	127	67	62	66	75	87	93
Accounts Receivable
Inventory	0	0	0	0	0								1									4	6	7	8	10	11	9	8	9	8	8
PP&E	0	0	0	0	0	1	1	1	1	2	3	3	4	5	6	6	8	8	9	9	9	9	11	11	11	13	13	16	16	16	17	19
Assets	6	6	6	17	16	31	29	46	43	41	82	75	70	63	53	45	139	126	111	97	83	74	148	136	126	213	218	201	185	172	159	147
Accounts Payable	0	0	0	0	0	0	0	0	1	1	1	1	2	2	2	2	3	3	2	2	1	1	2	1	2	3	2	2	1	3	2	2
Long-Term Debt										0	0	0	0	0	0	0	0									99				172	172	172
Liabilities	2	2	2	2	2	1	2	1	2	3	3	3	4	5	4	5	6	6	5	5	5	5	6	6	7	107	123	123	128	129	133	137
Stockholders' Equity	5	4	4	15	13	30	28	45	42	39	79	72	66	59	49	40	133	120	105	91	78	69	142	130	119	106	95	77	57	43	26	10


Income Statement ($MM)	2011-10-31	2012-01-31	2012-04-30	2012-07-31	2012-10-31	2013-03-31	2013-06-20	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	2	1	2	1	2	2	2	2
Cost of Revenue																						0	0	0	1	0	1	1	1	1	1	1
Gross Profit																						1	1	1	1	0	1	1	1	1	1	1
R&D	0	0	0	0	1	2	4	3	4	4	5	6	6	6	7	6	6	7	8	8	5	4	6	6	6	7	6	8		7	6	6
SG&A	0	0	0	2	1	1	1	1	1	2	4	3	3	3	5	4	6	7	9	9	10	11	11	12	11	14	15	12		13	13	13
Tax														1	0	0							0	0	0	0	0	0		0	0	-0
Net Income	-0	-0	-0	-4	-2	-3	-4	-4	-5	-5	-8	-9	-9	-9	-12	-11	-13	-15	-18	-17	-16	-14	-16	-17	-16	-21	-23	-22	-22	-22	-20	-20


Cash Flow ($MM)	2011-10-31	2012-01-31	2012-04-30	2012-07-31	2012-10-31	2013-03-31	2013-06-20	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	-0	-0	-0	-0	-1	-2	-3	-3	-3	-4	-4	-6	-5	-7	-9	-9	-10	-13	-15	-13	-13	-15	-13	-14	-13	-16	-19	-18		-20	-14	-17
Cash Investing	-0	-0	-0	-0	-0	-1	-1	-11	-1	-1	-2	-1	0	1	-3	-1	1	-34	-21	3	3	4	-20	-15	5	12	-63	12		25	25	21
Cash Financing					0	20	20	20	0	1	45	-0	0	0	0	0	104	-1	1	1	1	2	85	1	2	102	23	1		4	1	2